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The most common symptoms in chronic obstructive pulmonary disease (COPD) patients are
breathlessness and exercise limitation. Although both general and inspiratory muscle
training have shown clinical beneﬁts, the effects of speciﬁc expiratory muscle training
remain controversial.
Objective: To investigate the effects of expiratory training on lung function, exercise
tolerance, symptoms and health-related quality of life in severe COPD patients.
Methods: Sixteen patients (FEV1, 2878% pred.) were randomised to either expiratory
muscle or sham training groups, both completing a 5-week programme (30min sessions
breathing through an expiratory threshold valve 3 times per week) (50% of their maximal
expiratory pressure (MEP) vs. placebo, respectively). Lung function, exercise capacity
(bicycle ergometry and walking test), and clinical outcomes (dyspnoea and quality of life
(St. George Respiratory Questionnaire (SGRQ)) were evaluated both at baseline and
following the training period.
Results: Although lung function remained roughly unchanged after training, exercise
capacity, symptoms and quality of life signiﬁcantly improved. The improvement in both
walking distance and the SGRQ score signiﬁcantly correlated with changes in MEP.Elsevier Ltd. All rights reserved.
by Spanish Grants from FUCAP, SEPAR, FIS (98/1143) and ISC III (RTIC C03/11), as well as by a Grant of
-3406). Very preliminary results were presented at the European Respiratory Society Annual Congress,
248 31 38; fax: +34 93 221 32 37.
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Clinical outcomes of expiratory muscle training 517Conclusion: Our results conﬁrm that a short outpatient programme of expiratory training
can improve symptoms and quality of life in severe COPD patients. These effects could be
partially explained by changes in expiratory muscle strength.
& 2006 Elsevier Ltd. All rights reserved.Introduction
The efﬁcacy of pulmonary rehabilitation on chronic ob-
structive pulmonary disease (COPD) patients has been
demonstrated in many studies.1,2 Although pulmonary
rehabilitation is a multi-dimensional therapy, muscle train-
ing appears to be its most effective component. This is not
surprising since muscle dysfunction is common in COPD
patients and, at least in part, appears to be the result of
muscle deconditioning. General exercise, the training
modality supported by the strongest evidence (level A) has
been shown to improve exercise tolerance, dyspnoea and
health-related quality of life.2–4 Clinical beneﬁts of speciﬁc
ventilatory muscle training, however, have remained equi-
vocal.5 Nevertheless, different recent studies have shown
that when training loads are well controlled, inspiratory
training can induce speciﬁc improvements in the strength
and endurance of inspiratory muscles, as well as a decrease
in dyspnoea sensation both at rest and during exercise.6–8
Therefore, it is currently accepted that inspiratory training
is a meaningful addition to pulmonary rehabilitation
programmes, mostly in those COPD patients with inspiratory
muscle weakness.7,9 However, the role of expiratory muscle
training in COPD patients is much less well understood. On
one hand, there is a relative paucity of data on expiratory
muscle role in chronic respiratory conditions, on the other
hand, the prevalence of expiratory muscle dysfunction and
its impact in general clinical outcomes is unclear. Finally,
the studies evaluating speciﬁc expiratory training pro-
grammes are rather scarce.
Expiratory muscles have been found to be active in COPD
patients both at rest and during exercise, mostly at the end
of expiration.10,11 Moreover, these muscles are progressively
recruited during bronchospasm and ventilatory loading.12,13
Finally, they are essential for coughing and therefore, the
clearance of the airways. However, these actions do not
appear to result in signiﬁcant muscle conditioning (training
effect) in COPD patients. Although their maximal strength
can be either only mildly decreased or relatively main-
tained,14–17 COPD patients can actually suffer from pro-
gressive expiratory muscle dysfunction as expressed by a
reduced endurance and early appearance of fatigue.16
Moreover, even normal subjects can develop expiratory
muscle fatigue during heavy ventilatory efforts.18,19 There-
fore, it is more likely that expiratory muscles of COPD
patients, which persistently work under the overloads of
increased airway resistance and decreased lung elastic
recoil,20 would develop muscle dysfunction. It should be
recognised, however, that the intensity of expiratory muscle
dysfunction appears to be relatively low if compared with
weakness shown by COPD patients in peripheral or inspira-
tory muscles.14–17
Weiner et al.17 recently reported that a 3-month
programme of partially supervised expiratory muscle train-ing using a threshold device was able to induce a signiﬁcant
increase in exercise capacity. These results were conﬁrmed
in a second study by the same authors.21 However, the
beneﬁts of expiratory training programme were lower than
those achieved with inspiratory training alone, and similar
to those obtained by combining inspiratory plus expiratory
components.21 Nevertheless, the paucity of data does not
allow for deﬁnitive conclusions. In addition, as previously
demonstrated for inspiratory muscles, the intensity, fre-
quency and duration of the loads, as well as the proﬁle of
the candidates, are determinant, and essential in the
interpretation of data.6,22,23
The aim of the present study was to conﬁrm the clinical
beneﬁts of a speciﬁc expiratory muscle training, and to
provide new information about the effects of a relatively
short training programme (only 5 weeks) on respiratory
function, exercise capacity, dyspnoea and health-related
quality of life in severely obstructed COPD patients. These
outcomes can be considered as the main short-time targets
in the treatment of these patients.Methods
Patients
We studied patients with COPD in stages III (severe) or IV
(very severe) according to GOLD classiﬁcation23 (FEV1/
FVCo70% and FEV1 o50% pred.). Exclusion criteria were a
positive bronchodilator response (FEV1 increase 4200ml
after 200 mg of inhaled salbutamol), chronic respiratory
failure (PaO2 lower than 60 Torr), abnormal body mass index
(BMI) 430 or o20 kg/m2, bronchial asthma, coronary
disease, chronic metabolic or orthopaedic diseases, recent
abdominal or thoracic surgery, and/or treatment with
corticosteroids, hormones or chemotherapy. The patients
were simultaneously participating in parallel studies aimed
at investigating phenotypic changes induced by different
training programs in respiratory muscles. All subjects gave
their written informed consent prior to their participation in
the study.Study design
The protocol followed the World Medical Association guide-
lines for research on humans24 and was approved by our
institutional ethical committees. After a 4-week run-in
period, during which their clinical stability was veriﬁed, the
patients were randomised to either expiratory muscle
training or sham training. Clinical and physiological mea-
surements were performed before and at the end of the
programme, and the research team was blind regarding the
assigned training or sham groups.
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Table 1 Baseline characteristics of study subjects.
Sham training
(n ¼ 6)
Expiratory
training
(n ¼ 10)
Age, yr 6673 6272
Height, cm 16773 16872
Weight, kg 6775 6774
FEV1, % pred. 287 3 2773
TLC, % pred. 11571 13176
MEP, % pred. 7279 6876
DLCO, % pred. 4878 4676
PaO2, Torr 6872 7272
PaCO2, Torr 4673 4472
_VO2 max , pred. 5975 5377
60WT distance , m 430747 421734
Values are represented as x7SEM. Abbreviations: DLco,
carbon monoxide diffusing coefﬁcient; PaO2 and PaCO2,
arterial blood partial pressures for oxygen and carbon
dioxide, respectively; _VO2 max, maximal oxygen uptake
(cycloergometry); 60WT, 6-min walking test.
S. Mota et al.518Training programme
Training was done at the hospital under the supervision of an
experienced physiotherapist. During the 1st week, patients
received 3 sessions of general chest physiotherapy techni-
ques (relaxation and postural drainage). From the 2nd to the
6th week both the control and the training groups had three
30-min sessions per week breathing through an expiratory
threshold device.25 The load in the training group was
equivalent to around 50% of their maximal expiratory
pressure (MEP) whereas no additional loads were used in
the sham training group. Initially, repeated cycles of 3min of
work followed by 2min of rest were conducted (total work-
time 18min). The length of work intervals was increased on
a weekly basis while rest periods were shortened to obtain a
total work time of 30min in the last week of the
programme. The valve opening pressure was continuously
monitored at the mouthpiece to ensure the achievement of
the target pressure. At the end of each session, 15min of
general abdominal muscle exercises were also used in the
training group.
Lung function
Forced spirometry, as well as inspiratory capacity (IC),
maximal voluntary ventilation, plethysmographic lung vo-
lumes, carbon monoxide transfer coefﬁcient (DLco), arterial
blood gases, and MEP were determined as described in
previous articles,6,16 and are expressed as percentages of
appropriate reference values.26–29
Exercise tests
This included a 6-min walking test (60WT), leg cycloergo-
metry and arm cycloergometry. The 60WT30,31 was per-
formed along a hospital corridor with continuous pulse
oximetry monitoring. Both pre- and post-test dyspnoea
(Borg scale) and distance walked were recorded. Each
patient received instructions about the test and standar-
dised encouragement to walk covering as much ground as
possible. We performed 2 tests, with at least 30min rest
between them, and the highest distance obtained in the two
tests was chosen. Incremental bicycle ergometry to voli-
tional exhaustion was also performed for both upper and
lower limbs using the classical protocol described by Jones
and Campbell32 Dyspnoea as well as limb symptoms were
assessed (Borg scales) at baseline, every 2min and at the
end of the incremental limb exercise tests. Physiological
variables were analysed at three different levels: maximal
effort, 70% of pre-training peak O2 uptake, and 60% of
maximal voluntary ventilation.
Dyspnoea and health-related quality of life
Dyspnoea during daily activities was evaluated using a
modiﬁed Medical Research Council (MRC) scale,33 whereas
quality of life was assessed using the St. George’s
Respiratory Questionnaire (SGRQ) in its Spanish version.34,35
The latter is an instrument, speciﬁc for COPD, which
includes three different scales evaluating symptoms, activ-
ity and impact. The overall and each scale scores range from0 to 100 (from no change to maximum change in quality of
life, respectively).
Statistical analysis
Values are expressed as mean and standard error (x7SEM).
Baseline and post-training data were compared within
groups using the Wilcoxon test for paired samples. The
Mann–Whitney U-test was used to compare data and
percentages of change between both groups. Correlations
were studied by calculating the Spearman coefﬁcient. A P
value o0.05 was considered statistically signiﬁcant.
Results
Eighteen male COPD patients were initially enroled (8 for
the control group and 10 for the expiratory training group).
However, two patients in the sham training group did not
ﬁnish the study: one because of a COPD exacerbation and
the other due to a gouty arthritis episode. The main baseline
characteristics of all patients who ﬁnished the programme
were similar in the 2 groups (Table 1). All patients had
severe-to-very severe airway obstruction and most also had
air trapping, decreased CO transfer coefﬁcient, expiratory
muscle dysfunction and mild-to-moderate hypoxaemia.
Respiratory function
Following expiratory training lung function remained essen-
tially unchanged (Table 2 and Fig. 1a). However, MEP
increased by 19%. No signiﬁcant changes were observed in
the sham group. When percentages of change following
intervention were used to compare both groups, no
differences were observed for respiratory function variables
except for MEP. However, hyperinﬂation showed a slight
tendency to be lower in those patients belonging to the
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Table 2 Lung function data before (baseline) and after (end) training.
Sham training (n ¼ 6) Expiratory muscle training (n ¼ 10)
Baseline End Baseline End
FVC, L 2.6470.19 2.8870.23 2.8070.13 2.9670.10
FEV1, L 0.8470.07 0.9170.08 0.8770.08 0.8670.07
FEV1/FVC, % 3274 3273 3272 2972
IC, L 1.7270.16 1.8970.14 1.4770.16 1.7270.08
FRC, L 5.0870.19 4.970.25 6.4270.45 6.1370.39
RV, L 4.1470.21 3.9070.29 5.0970.49 4.8170.43
TLC, L 6.8070.32 6.7970.36 7.8970.48 7.7770.40
RV/TLC, % 6172 5773 6373 6173
MEP, cm H2O 130710 13178 123712 147712*
For abbreviations see the text. *Po 0.05 in the comparison of pre- and post-training values.
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Figure 1 (a) Mean changes observed in representative variables of respiratory function following either sham training or expiratory
muscle training. (b) Mean changes in exercise variables observed after training. From left to right, parameters corresponding to leg
cycloergometry, arm cycloergometry and the 6min walking test. *Po0.05.
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S. Mota et al.520trained group (their increase in IC was 17% vs. only 9.8% in
the control group, P ¼ 0.10).4
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The main variables obtained when exercising are shown in
Table 3 and Fig. 1b. The distance walked during the 60WT
signiﬁcantly improved after muscle training (13%), with no
changes in the sham group. In addition, the change in the
level of dyspnoea from baseline to the end of the walking
test shown by trained patients was signiﬁcantly better than
that of controls (20 vs. 0%, respectively) Moreover, although
no signiﬁcant changes were observed in the incremental
limb exercise tests in either trained or control patients, the
analysis of the percentages of change in each group
evidenced signiﬁcant differences favouring trained patients
in maximal workloads obtained in either leg or arm
cycloergometries (12% and 11% vs. 3% and 5%, respec-
tively, Po0.05 both). In addition, the improvement in
exertional dyspnoea observed in trained patients for the
latter test was signiﬁcantly higher than that shown by the
sham group (Po0.05) (Fig. 1b).SG
R -16 Symptoms
-20
Activity
-24
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Figure 2 Mean changes in the St. George Respiratory Ques-
tionnaire (SGRQ) scores observed after the expiratory training
programme. White bars correspond to the symptoms score;
striped bars to the activity score; grey bars to the impact score;
and black bars to the global SGRQ score. **Po0.01.Dyspnoea at rest and health-related quality of life
The MRC scores showed that dyspnoea at rest improved in
the training group (371 vs. 271, Po0.01) but not in the
sham group (272 vs. 271). In addition, the former group
showed a signiﬁcant decrease in the SGRQ overall score, and
speciﬁcally in symptoms and impact domains, after the
programme (Fig. 2).Table 3 Exercise variables before and after training.
Sham training (n ¼ 6)
Baseline End
Legs incremental exercise test
Wmax, Kpm/min 500782 483760
_VO2 max , L/min 0.9670.10 0.8870.0
_VE , L/min 3675 3475
VT , L 0.9770.11 0.9970.1
VT/TI, L/s 1.670.22 1.4970.2
Breathlessness, Borg 871 871
Arms incremental exercise test
Wmax, Kpm/min 200743 190730
_VO2 max , L/min 0.8170.08 0.7570.0
Breathlessness, Borg 771 870
Six-min walking test
Distance, m 430747 423745
Breathlessness, Borg 371 371
All data correspond to the maximal effort in each test. Wmax, indicate
minute ventilation; VT, tidal volume; VT/TI, mean inspiratory ﬂow. *P
training values.Correlations of changes induced by training
The increase in expiratory muscle strength observed in
the trained group correlated with the improvements in
both the distance walked, and the activity, impact and
global scores obtained in the SGRQ (Fig. 3). Finally, a
signiﬁcant relationship was found between changes in
exertional dyspnoea measured at the end point of the
60WT and changes in the QoL assessment with global scale,
r ¼ 0.634, Po0.05).Expiratory muscle training (n ¼ 10)
Baseline End
420754 470756
9 0.9370.10 0.9470.08
3373 3574
2 0.9170.06 0.9970.06
5 1.4570.14 1.6670.14*
771 771
185726 205732
4 0.8870.08 0.8270.07
771 671
421734 474732**
571 470
s maximal work rate; _VO2 max, maximal oxygen consumption; _VE,
p0.05 and **Po0.01 in the comparison between pre- and post-
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Figure 3 Relationships between changes in maximal expiratory pressure (MEP) following the training period on one hand, and
modiﬁcations in (a) the distance obtained in the 60WT, as well as in (b) the activity score, (c) the impact score and (d) the global score
obtained in the SGRQ, on the other. Open squares represent trained patients while closed squares correspond to the control group.
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The main ﬁnding of the present study is the signiﬁcant
improvement in dyspnoea at rest, health-related quality of
life, and timed walking distance in COPD patients following
a short expiratory muscle training period. Most of these
changes were proportional to the improvement in expiratory
muscle strength. It should be noted that improvements in
SGRQ scores and walking test distance were not only
statistically signiﬁcant but also should be considered
clinically relevant.34–36 The complementary analysis of
differential changes in trained and control groups also
revealed that improvements were greater in the formerregarding maximal workloads obtained in either arm or leg
cycloergometries, as well as in exertional dyspnoea in both
the 60WT and the upper limb exercise.
Although expiratory muscles have been little studied, it is
known that in COPD patients these muscles can exhibit
weakness, as evidenced by either mild reductions in
maximal force and/or endurance.15–17,20 Since muscle
weakness might be improved through different mechanisms
by training, we hypothesised that a speciﬁc expiratory
training programme using an appropriate schedule would
promote clinical beneﬁts. This study was designed to
respond to the relative lack of information about the impact
of expiratory training on symptoms, quality of life and
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conﬁrm our initial hypothesis. The signiﬁcant increase of
expiratory muscle strength and its close correlation with the
improvement in certain exercise and life-quality variables,
strongly suggest a causative role for the former mechanism.
Although MEP manoeuvre is volitional and therefore, can be
biased by learning, the absence of changes in the control
group strongly argues for an actual increase in expiratory
muscle strength in trained patients. Our ﬁndings are also
consistent with the results of Weiner et al.17 regarding the
beneﬁts of expiratory training in exercise tolerance since
submaximal exercise capacity (as measured by the walking
test) increased signiﬁcantly, and maximal work also tended
to increase in both arm and leg incremental exercise tests.
The observation of an improvement in dyspnoea during
activities of daily living as well as in health-related quality
of life following expiratory training in severe COPD are
probably the most relevant ﬁndings for the clinical practise.
The perception of breathing difﬁculty during everyday tasks
is modulated by physical, psychological and socio-cultural
factors and it is known to be the main component of health-
related quality of life in such patients.34,35 When Suzuki
et al.37 studied the effects of speciﬁc expiratory training in
healthy individuals, they were able to provide evidence of
improved strength and reduced sensation of respiratory
effort. Weiner et al.17,21 however, found no signiﬁcant
changes in dyspnoea (measured by Mahler’s baseline and
transitional indices) after expiratory muscle training in a
group of less severely obstructed COPD patients, who in any
case had a more limited exercise capacity than ours. The
differences between study populations, training protocols
and instruments of measurement could explain the dis-
crepancy, although it may also be attributable to insufﬁcient
statistical power.
In accordance with dyspnoea changes observed in the
present study, health-related quality of life (not previously
evaluated by Weiner et al.)17,21 also improved signiﬁcantly
in our patients, both phenomena being statistically asso-
ciated. This ﬁnding itself denotes the achievement of a
capital goal for an integrated COPD treatment, since quality
of life appears to have an independent prognostic value in
the natural history of the disease, in terms of use of health
resources, hospitalisation rates and survival.38
According to our results, four different possible mechan-
isms may have been implicated in the clinical improvement
observed in COPD patients following expiratory training.
First of all, a decrease in work-related oxygen consumption
for the expiratory muscles. Since breathing pattern,
ventilation, oxygen saturation, and heart rate during the
exercise tests did not change following training, and peak
oxygen uptake remained the same while maximal work
tended to increase, clinical improvement could be a product
of favourable changes in local expiratory muscle metabolism
(i.e. a decrease in their oxygen consumption). Although the
level of the stimulus delivered by the training programme
used in the present study is theoretically able to induce
aerobic adaptation within muscle ﬁbres,6 the methodologi-
cal approach required to test this hypothesis necessarily
would need further studies.
The second mechanism for clinical beneﬁts observed
following training in our COPD patients is a potential
desensitisation to dyspnoea. The patients in our treatmentgroup walked a statistically signiﬁcant and clinically mean-
ingful greater distance on the walking test, without an
increase in Borg-rated dyspnoea. In fact, when analysing
percentages of change in both trained and control patients,
signiﬁcant improvements favouring the former group were
observed both in the walking test and arm cycloergometry in
spite of increases in the workloads in both tests. Moreover,
the perception of dyspnoea at maximal leg exercise did not
change regardless of the greater improvement in workload
reached by trained patients. All of this indicates an
effective decrease in their task-related sensation of breath-
lessness. This perception is known to be a complex process
in which the implicated factors are mainly those that
promote increased output by respiratory system motoneur-
ons39–42; and there is evidence that both inspiratory and
expiratory muscle subsequent efforts play a role in
generating the sensation of breathing effort.40
The third mechanism that would explain the clinical
improvement observed in our patients is a reduction in lung
volumes. We actually found that trained patients showed a
mild tendency to have less air trapping (as expressed by
different tendencies in FVC, inspiratory capacity, FRC and
RV). However, one might have expected that increased
expiratory strength would have favoured dynamic airway
compression during exhalation. Nevertheless, expiratory
muscle training may also act on the complex mechanisms
involved in hyperinﬂation in two other different ways. For
instance, by modifying the static equilibrium between the
lung and the chest wall (improving abdominal muscle tone
and elevating the diaphragm to diminish thoracic air
trapping)43; and/or by increasing expiratory muscle activity
to compensate for inspiratory muscle activity during
expiration.44 The absence of signiﬁcant correlations be-
tween the clinical beneﬁts of training and static lung
volumes in our study, however, argues against a role for
hyperinﬂation at rest. Although we did not investigate
dynamic hyperinﬂation during exercise, our observation of
an increased mean inspiratory ﬂow at peak exercise in
trained patients may reﬂect changes in inspiratory muscle
activity as a by-product of mechanical modiﬁcations (such as
a reduction in end-expiratory volume). However, it seems
unlikely that a clinically relevant decrease in dynamic
hyperinﬂation took place in patients who probably became
ﬂow-limited during exercise.43
Finally, the expiratory muscle training could have led to a
more effective cough and therefore, a more efﬁcient
clearance of the airways. This was not assessed in our
study. However, even if coughing capacity has been
improved, it is unlikely that this would have a relevant role
in our patients, who were clinically stable and non-
bronchorrheic, with a daily sputum volume that was less
than 30mL according to our records.
General muscle training is probably the most widely used
component in rehabilitation programs. Alone or combined
with inspiratory muscle training, it has been clearly shown
to induce clinical changes in COPD patients.1–3,5,6 However,
in keeping with some other recent reports,17,21 our results
clearly indicate that speciﬁc expiratory muscle training is
also capable of inducing desired clinical beneﬁts in severely
obstructed COPD patients. In our experience this sort of
training is easy to incorporate into clinical practise and has
no adverse effects. Furthermore, its simplicity suggests that
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at home, given a few supervised sessions to ensure correct
procedure on the part of the patient. However, the actual
feasibility of expiratory training home application should be
evaluated in further studies. The efﬁcacy of expiratory
muscle training in comparison with the training of other
muscle groups also warrants investigation. In this respect, as
previously mentioned, Weiner and McConell9 does not favour
expiratory in front of inspiratory training, for two main
reasons. In the ﬁrst place, they reported greater improve-
ment in the 6-min walked distance after inspiratory muscle
training than after expiratory training, with no additional
beneﬁts resulting from the combination of both modal-
ities.21 In contrast, our group did not ﬁnd signiﬁcant changes
in exercise capacity in a group of very obstructed COPD
patients after a short inspiratory training programme
structured in a similar way to the expiratory training used
in the present study.6 The second ﬁnding that caused Weiner
and McConell9 not to favour expiratory training over
inspiratory training is that it was only after the latter that
they found an improvement in dyspnoea at rest. We,
however, did ﬁnd an improvement after expiratory training.
Discrepancies between their observations and ours remain
an interesting question to explore but, as mentioned above,
they are probably related to differences in protocols and
patient proﬁles.
Our study has some limitations derived from the relatively
small number of patients ﬁnally included. However, this is a
restriction common to many other randomised placebo
controlled studies and can be partially counterbalanced by
comparison between percentages of change in different
groups. On the other hand, although this limitation might
seem to imply that our conclusions should be taken
cautiously, the coincidence with ﬁndings obtained in
previous studies strongly argues for their consistence.
To sum up, we conﬁrm that speciﬁc expiratory muscle
training improves functional exercise capacity as assessed
by timed walking distance, and decreases dyspnoea during
daily living activities, resulting in a better health-related
quality of life in patients with severe COPD. Although our
understanding of the physiological mechanisms underlying
these beneﬁts is not complete, our results suggest that they
are directly related to changes occurring in expiratory
muscle physiology.Acknowledgements
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